SD

Susan Dillon

President & CEO

Aro Biotherapeutics

Philadelphia, Pennsylvania


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Aro Biotherapeutics
Industry
biotechnology
Employees
53.0
Seniority
C suite
Annual Revenue
6000000.0
Total Funding
171532627.0
Latest Funding
Series B

Professional Summary

Susan Dillon serves as President & CEO at Aro Biotherapeutics. Aro Biotherapeutics operates in the biotechnology sector with approximately 53.0 employees. The company is headquartered in Philadelphia, Pennsylvania. Aro Biotherapeutics generates annual revenue of 6000000.0. To date, Aro Biotherapeutics has raised 171532627.0 in total funding, with the most recent round being Series B.

Industry & Role Insights

  • MessageCEO tracks 381 executives in the biotechnology sector.
  • We have verified contacts for 2 executives at Aro Biotherapeutics.
  • 2,637 executive contacts are available in Pennsylvania.
  • Our database includes 201,469 c suite-level executives.

Technologies

DNS Made Easy Outlook Google Cloud Hosting Google Font API Google Analytics Mobile Friendly Varnish Wix Google Tag Manager Breezy HR (formerly NimbleHR) Remote

Keywords

drug discovery drug development licensing drug delivery sirna immunology bispecifics protein conjugation protein therapeutics oligonucleotide delivery protein engineering targeted nanoparticles genetic medicine tissuespecific targeting biotechnology centyrin platform rna therapeutics targeted delivery gene modulation therapeutic candidates clinical trials oligonucleotide-based drugs sirna conjugates tissue-targeted therapies disease treatment precision medicine bioconjugation therapeutic payloads disease-specific targets biotherapeutics pipeline development clinical development disease tissue targeting genetic disorders research publications scientific collaboration biotech partnerships translational research novel therapeutics patient-centric treatments pharmaceutical innovations investor relations biotech investment advanced therapies extraction-to-clinic efficacy & safety disease management unmet medical needs gene delivery systems therapeutic efficacy drug formulation biotech leadership scientific advisory board biological engineering fda approval processes innovative drug solutions biotech advancements healthcare solutions medical research health care health wellness & fitness hospital & health care

Related Executives

SS
Sukumar Sakamuri Chief Technology Officer at Aro Biotherapeutics
CB
Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio
JL
Jason Loveridge CEO at 4SC AG
MM
Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant
JR
Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

Frequently Asked Questions

How can I contact Susan Dillon?

Susan Dillon's verified email address is available on MessageCEO. They currently work at Aro Biotherapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Susan Dillon lead?

Susan Dillon is President & CEO at Aro Biotherapeutics, a company in the biotechnology sector with 53.0 employees. The company is based in Philadelphia, Pennsylvania.

What industry is Susan Dillon in?

Susan Dillon works in the biotechnology industry as President & CEO at Aro Biotherapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Susan Dillon's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Susan Dillon's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: April 11, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans